Intarcia PDUFA passes without update
It has been observed that Intarcia’s March 9 PDUFA date for ITCA-650 has passed. To the best of FENIX’s knowledge, there has been no company announcement from Intarcia and no new NDA database entries seen in an Orange Book search. Recall, after receiving a Sept 2017 CRL, Intarcia re-filed the ITCA-650 NDA on or around September 9, 2019, with a subsequent acceptance announcement on October 8, 2019 (previous FENIX insight). FENIX will provide analysis and market implications once a company announcement is made from Intarcia.
About The Author
Matthew has been a thought leader in the high-growth therapeutic areas of diabetes and cardiovascular medicine since 2006, making regular attendance at large and small CV/met scientific meetings and an architect of novel methods for assessing market opportunities. He has over a decade of experience in leading CV/met consulting engagements, is a published author in PM360 and Diabetes Technology & Therapeutics, and has been quoted in The Pink Sheet on anti-thrombotics.
If you receive our email blasts, you already have an account. Log in now
You can read the article’s full content online after purchase.